Detalhe da pesquisa
1.
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.
Br J Haematol
; 200(1): 45-53, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36205375
2.
Thrombosis in multiple myeloma: mechanisms, risk assessment and management.
Leuk Lymphoma
; 64(12): 1905-1913, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584485
3.
COVID-19 among patients with hematological malignancies: a national Israeli retrospective analysis with special emphasis on treatment and outcome.
Leuk Lymphoma
; 62(14): 3384-3393, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34405767
4.
BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
Transl Res
; 207: 83-95, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30738861
5.
Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome.
Leuk Res
; 68: 9-14, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29501828